Rennova Health (NSDQ:RNVA) said today that it plans to spin off its advanced molecular services division into an independent, publicly-traded company. The spin-off is slated to take place at the end of September.
Rennova’s board has also cleared the spin-off of its health technology solutions arm in a similar deal, according to the company.
Get the full story at our sister site, Drug Delivery Business News.
